TY - JOUR
T1 - Quality of life among women diagnosed with breast Cancer
T2 - A randomized waitlist controlled trial of commercially available mobile app-delivered mindfulness training
AU - Rosen, Kristen D.
AU - Paniagua, Samantha M.
AU - Kazanis, William
AU - Jones, Shaun
AU - Potter, Jennifer Sharpe
N1 - Funding Information:
Preliminary work for this this study was supported by a research grant from the ThriveWell Cancer Foundation (J.S.P. & K.R.). This study was also the basis for Dr Rosen's doctoral dissertation and supported in part by a Graduate Student Research Award from the University of Texas at San Antonio (K.R.). Headspace provided in‐kind donations for 6‐month app subscriptions provided to study participants. The authors would like to thank Dr David Cox and Ms. Janis Martman for their assistance with the Headspace app and obtaining app log data. The authors also wish to thank Ms. Joseé Battle, Dr Deanna Attai, and the following breast cancer organizations for their assistance with recruitment: ThriveWell Cancer Foundation DIVA program, Breast Cancer Social Media (#BCSM) Community, http://breastcancer. org Community, Zero Breast Cancer, Young Survival Coalition, and Susan G. Komen San Antonio. Headspace had no involvement in the study design, self‐report data collection, data analysis and interpretation, and writing of the final report.
Publisher Copyright:
Copyright © 2018 John Wiley & Sons, Ltd.
PY - 2018/8
Y1 - 2018/8
N2 - Objective: The primary objective was to evaluate the efficacy of commercially available mobile app-delivered mindfulness training (AMT), compared with waitlist control (WC), on quality of life (QOL) among women diagnosed with breast cancer. The secondary outcome was dispositional mindfulness. Enrollment, app utilization, and study completion are reported as feasibility objectives. Methods: Women diagnosed with breast cancer ≤5 years (n = 112) were randomized to AMT (n = 57) or WC (n = 55), over 8 weeks, with 4 weeks of follow-up. We conducted linear mixed effects models to examine group by observation interactions on QOL and dispositional mindfulness at baseline, during intervention (5-weeks), post-intervention (9-weeks), and follow-up (12-weeks post-baseline). Results: Participants assigned to AMT reported higher QOL, compared with those assigned to WC, from baseline through follow-up t(258.40) = 3.09, P < 0.01, 95% CI [2.71, 11.90]. Participants assigned to AMT also reported higher dispositional mindfulness, compared with those assigned to WC, from baseline through follow-up t(268.44) = 2.04, P = 0.04, 95% CI [0.01, 0.57]. App utilization data was obtained from 34 participants. Fewer participants assigned to AMT completed all study assessments, compared with participants assigned to WC, (χ2 1 = 7.07, P = 0.008). Conclusions: Findings suggest commercially available AMT may proffer some benefit to women seeking to enhance their QOL following breast cancer diagnosis.
AB - Objective: The primary objective was to evaluate the efficacy of commercially available mobile app-delivered mindfulness training (AMT), compared with waitlist control (WC), on quality of life (QOL) among women diagnosed with breast cancer. The secondary outcome was dispositional mindfulness. Enrollment, app utilization, and study completion are reported as feasibility objectives. Methods: Women diagnosed with breast cancer ≤5 years (n = 112) were randomized to AMT (n = 57) or WC (n = 55), over 8 weeks, with 4 weeks of follow-up. We conducted linear mixed effects models to examine group by observation interactions on QOL and dispositional mindfulness at baseline, during intervention (5-weeks), post-intervention (9-weeks), and follow-up (12-weeks post-baseline). Results: Participants assigned to AMT reported higher QOL, compared with those assigned to WC, from baseline through follow-up t(258.40) = 3.09, P < 0.01, 95% CI [2.71, 11.90]. Participants assigned to AMT also reported higher dispositional mindfulness, compared with those assigned to WC, from baseline through follow-up t(268.44) = 2.04, P = 0.04, 95% CI [0.01, 0.57]. App utilization data was obtained from 34 participants. Fewer participants assigned to AMT completed all study assessments, compared with participants assigned to WC, (χ2 1 = 7.07, P = 0.008). Conclusions: Findings suggest commercially available AMT may proffer some benefit to women seeking to enhance their QOL following breast cancer diagnosis.
KW - cancer
KW - mindfulness
KW - mobile applications
KW - oncology
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85051175981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051175981&partnerID=8YFLogxK
U2 - 10.1002/pon.4764
DO - 10.1002/pon.4764
M3 - Article
C2 - 29766596
AN - SCOPUS:85051175981
SN - 1057-9249
VL - 27
SP - 2023
EP - 2030
JO - Psycho-Oncology
JF - Psycho-Oncology
IS - 8
ER -